They also suggest that we could probably hit skin tumors pharmacologically using combinations of drugs targeting different Vav-dependent Achilles’ heels specific for TSCs, transformed keratinocytes and, possibly, fibroblasts. Here, VAV1 is linked to skin neoplasm.